Baricitinib disappoints in SLE-BRAVE trials
![](https://www.medwirenews.com/wp-content/uploads/2023/04/AdobeStock_378228808mwn.jpg)
Baricitinib has achieved largely negative results in the SLE-BRAVE trials, published in The Lancet.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.